Newsletters
 | Selecting Optimal Therapy for Patients with Hemophilia CME, CPE Meera B. Chitlur, MD | |
| Release Date: February 20, 2023 Expiration Date: February 20, 2024 | ||
| In this newsletter, Dr. Meera Chitlur discusses the role of prophylaxis, individualizing treatment options, and how new therapies impact practice. She explains the remaining challenges of using longer-acting therapies and how individualizing therapy can improve adherence. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from CSL Behring, LLC. | ||
| Begin, Earn CreditView Only, No Credit | ||
 | Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia CME, CPE Steven W. Pipe, MD | |
| Release Date: July 29, 2022 Expiration Date: July 29, 2023 | ||
| Join Dr. Pipe as he outlines new innovations and findings relative to hemophilia A and B. Topics include gene therapy, anti-tissue factor pathway inhibitors, and other exciting developments in hemophilia. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from CSL Behring, LLC. | ||
| Begin, Earn CreditView Only, No Credit | ||